Raj Ganguly

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers

Journera is a travel technology company. We partner with travel providers, marketers, and technologists to bring together a real-time view of a traveler’s journey. With the secure and private exchange of shared customer data, we elevate travel experiences, strengthen loyalty, increase direct engagement, and facilitate operational efficiencies. For more information, visit https://journera.com/ or contact info@journera.com

INTURN is now Vue.ai - the only enterprise AI platform that puts you on the course for your first, quick AI ROI win. Within 90 days. Whether in retail or finance, staffing or insurance, no more 3-year AI transformation plans. Ditch the data treadmill, ramp up to peak productivity and Go-Live today. With the only enterprise AI platform that delivers on business outcomes – obsessively. Stay in the mix, folks. Website: https://www.vue.ai LinkedIn: https://www.linkedin.com/company/vue-ai/ Twitter: https://twitter.com/Vue_ai Instagram: https://www.instagram.com/vue.ai/

Winmore is the market leader in providing AI-driven price and process optimization.

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe.

Audi on demand is a premium app-based car rental service offered at participating Audi dealerships nationwide. Together with Audi, we help to create the future of mobility, focused on drivers’ needs. Audi on demand provides customers with flexible short term rental and long term drive options on a fleet of new Audi vehicles. The service began in 2012 as Silvercar, and was acquired by Audi in 2017.

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers

Journera is a travel technology company. We partner with travel providers, marketers, and technologists to bring together a real-time view of a traveler’s journey. With the secure and private exchange of shared customer data, we elevate travel experiences, strengthen loyalty, increase direct engagement, and facilitate operational efficiencies. For more information, visit https://journera.com/ or contact info@journera.com

INTURN is now Vue.ai - the only enterprise AI platform that puts you on the course for your first, quick AI ROI win. Within 90 days. Whether in retail or finance, staffing or insurance, no more 3-year AI transformation plans. Ditch the data treadmill, ramp up to peak productivity and Go-Live today. With the only enterprise AI platform that delivers on business outcomes – obsessively. Stay in the mix, folks. Website: https://www.vue.ai LinkedIn: https://www.linkedin.com/company/vue-ai/ Twitter: https://twitter.com/Vue_ai Instagram: https://www.instagram.com/vue.ai/

Winmore is the market leader in providing AI-driven price and process optimization.

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe.